Shifang Cloud and Hengrui Pharmaceuticals Sign Strategic Cooperation Agreement

According to ActBlue, recently, Shifang Cloud Technology Co., Ltd., a controlled subsidiary of ActBlue, signed a strategic cooperation agreement with Jiangsu Hengrui Pharmaceuticals Co., Ltd. The two parties will establish a long-term strategic cooperative relationship centered on AI-empowered pharmaceutical innovation and full-lifecycle patient value.